Notice Number: NOT-DK-18-021
Key Dates
Release Date: August 1, 2018
Issued by
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Purpose
The purpose of this Notice is to clarify the application types allowed for RFA-DK-18-012, Human Islet Research Enhancement Center for the Human Islet Research Network (U24 Clinical Trial Not Allowed). In Section II. Award Information: Application Types Allowed, the first appearance of the word "Renewal" is being deleted. Only renewal grants funded under RFA-DK-13-013 will be accepted under this Funding Opportunity Announcement.
Currently reads:
Application Types Allowed
New
Renewal
Renewal applications from RFA-DK-13-013.
The OER Glossary and the SF424 (R&R) Application Guide provide details on these application types.
Revised to read:
Application Types Allowed
New
Renewal applications from RFA-DK-13-013.
The OER Glossary and the SF424 (R&R) Application Guide provide details on these application types.
All other aspects of this Funding Opportunity Annnouncement remain the same.Inquiries
Please direct all inquiries to:
Thomas Eggerman, M.D., Ph.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: 301-594-8813
Email: [email protected]